Oncology & Cancer

Researchers discover key to making cancer-killing peptides

Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, ...

Diseases, Conditions, Syndromes

Dynamics of adaptive immunity in tuberculosis uncovered

Unlike other infectious diseases that affect the lungs, the immune response to fight tuberculosis (TB) infections develops at least twice as slowly. Until recently, the dynamic interplay between bacteria and the host's immune ...

Oncology & Cancer

Giving tumor vaccines a proper introduction

Given how effectively the immune system can eliminate foreign threats such bacteria and viruses, hopes are high for the development of strategies that might turn these same defense mechanisms against cancerous targets. However, ...

Diseases, Conditions, Syndromes

Bacterial toxin a potential trigger for multiple sclerosis

Researchers from Weill Cornell Medical College have added to the growing body of evidence that multiple sclerosis may be triggered by a toxin produced by common foodborne bacteria. The presented their research at the 2014 ...

Diseases, Conditions, Syndromes

Drugs to block angiogenesis could provide new treatment for TB

The body responds to tuberculosis infection by locking the bacterial offenders into tiny clusters of immune cells called granulomas, which are a hallmark of the disease. This containment strategy succeeds at first, but eventually ...

page 31 from 40